ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,674 | +127.5% | 12,200 | +256.7% | 0.00% | – |
| Q2 2023 | $16,997 | -57.9% | 3,420 | -58.1% | 0.00% | – |
| Q1 2023 | $40,334 | -48.9% | 8,165 | -35.1% | 0.00% | – |
| Q4 2022 | $79,000 | -59.7% | 12,588 | -30.5% | 0.00% | – |
| Q3 2022 | $196,000 | -37.8% | 18,109 | -34.5% | 0.00% | -100.0% |
| Q2 2022 | $315,000 | +205.8% | 27,638 | +143.1% | 0.00% | – |
| Q1 2022 | $103,000 | -35.6% | 11,368 | +6.0% | 0.00% | – |
| Q4 2021 | $160,000 | -39.8% | 10,728 | +3.5% | 0.00% | -100.0% |
| Q3 2021 | $266,000 | +25.5% | 10,369 | +27.4% | 0.00% | – |
| Q2 2021 | $212,000 | -0.9% | 8,138 | +34.9% | 0.00% | -100.0% |
| Q1 2021 | $214,000 | +103.8% | 6,031 | +44.7% | 0.00% | – |
| Q4 2020 | $105,000 | +54.4% | 4,169 | +131.6% | 0.00% | – |
| Q3 2020 | $68,000 | -5.6% | 1,800 | +7.4% | 0.00% | – |
| Q2 2020 | $72,000 | +118.2% | 1,676 | -0.1% | 0.00% | – |
| Q1 2020 | $33,000 | – | 1,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |